9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning

9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning

Toxic Byproducts & Critical Safety Monitoring

Inhaled nitric oxide carries the risk of significant biochemical toxicities. Strict continuous monitoring and serial laboratory evaluations are mandatory.

Monitoring the Two Principal Toxic Exposures

Delivery-System Safety

• Use only a compatible calibrated delivery system and place the injector and sampling line exactly as its operating manual specifies.
• Continuously display delivered NO, inspired $NO_2$, and $FiO_2$; keep backup power and an independent reserve delivery system available.
• Trend oxygenation, blood pressure, perfusion, pulmonary pressure, and ventricular function. Systemic hypotension or new pulmonary edema requires immediate reassessment.

---

Stepwise Weaning Protocol & Preventing Rebound Pulmonary Hypertension

Abrupt discontinuation can cause rebound pulmonary hypertension with worsening oxygenation, hypotension, bradycardia, or low cardiac output and must be avoided.

[Clinical improvement and an explicit weaning order]
                    |
                    v
[Reduce iNO in several protocol-defined steps]
                    |
                    v
[Pause at each step; observe SpO2, FiO2, pressure, perfusion and echo data]
                    |
          stable? --+-- no --> [Return to prior effective dose and reassess]
                    |
                   yes
                    v
[Discontinue from a low dose with bedside observation and prescribed oxygen]

The Pathophysiology of Rebound PPHN

Abrupt withdrawal can cause rebound pulmonary vasoconstriction and hypoxemia through loss of the inhaled vasodilator and altered endogenous signaling. The response ranges from modest desaturation to severe pulmonary-hypertension and right-ventricular decompensation, especially when disease remains active. Prevent it with staged weaning and immediate monitoring.

Weaning Execution Rules

1. Wean in protocol-defined steps only after lung disease, hemodynamics, and pulmonary hypertension are improving.
2. Many neonatal pathways taper to a low dose such as 1 ppm before discontinuation, watching saturation, OI, pressure, and right-ventricular function after every step. Dwell time varies.
3. Some protocols temporarily adjust FiO2 around final discontinuation. Avoid an automatic 10%–20% increase; use the lowest oxygen needed for the prescribed target and reverse the prior iNO step promptly if rebound occurs.

---

Worked Clinical Calculation: Oxygenation Index & iNO Response

Clinical Scenario

A 39-week gestational age male infant weighing $3.6\text{ kg}$ is delivered via emergency cesarean section for meconium aspiration syndrome. The infant is intubated and mechanically ventilated in Pressure-Regulated Volume Control (PRVC) mode with the following parameters:

• Fraction of Inspired Oxygen ($FiO_2$): $1.00$ ($100%$)
• Mean Airway Pressure ($Paw$): $18\text{ cmH}_2\text{O}$
• Arterial Blood Gas ($ABG$): $pH\text{ }7.24$, $PaCO_2\text{ }52\text{ mmHg}$, $PaO_2\text{ }42\text{ mmHg}$, $HCO_3^-\text{ }22\text{ mEq/L}$, $BE\text{ }-4\text{ mEq/L}$
• Echocardiogram reveals suprasystemic right ventricular pressures with a right-to-left shunt across the ductus arteriosus.

Step-by-Step Clinical Calculation

1. Calculate Baseline Oxygenation Index (OI): $\text{OI} = \frac{Paw \times FiO_2 \times 100}{PaO_2} = \frac{18 \times 1.00 \times 100}{42} = \frac{1800}{42} \approx \mathbf{42.9}$ Interpretation: The OI of 42.9 confirms severe hypoxemic respiratory failure. The echocardiogram—not OI alone—establishes pulmonary-hypertension physiology. This high and worsening severity warrants an iNO trial under the neonatal protocol and urgent ECMO-center consultation; it does not make either therapy automatic.

2. Initiate Therapy:

   • Initiate inhaled nitric oxide at $20\text{ ppm}$.
   • Set saturation targets and alarms from the infant's prescription and diagnosis.
   • Verify calibrated NO, $NO_2$, and $FiO_2$ monitoring and set device alarms according to the cleared system and unit protocol.

3. Assess Post-Initiation ABG (30 Minutes Post-iNO):

   • Post-treatment parameters: $FiO_2\text{ }1.00$, $Paw\text{ }18\text{ cmH}_2\text{O}$, $PaO_2\text{ }110\text{ mmHg}$.
   • Calculate Post-Treatment OI: $\text{OI}_{\text{post}} = \frac{18 \times 1.00 \times 100}{110} = \frac{1800}{110} \approx \mathbf{16.4}$
   • Response Analysis:
     • Increase in $PaO_2 = 110 - 42 = +68\text{ mmHg}$ ($> 20\text{ mmHg}$ threshold).
     • Percent reduction in $\text{OI} = \frac{42.9 - 16.4}{42.9} \times 100% = 61.8%$ ($> 33%$ threshold).
     • Conclusion: This is a strong acute oxygenation response at unchanged support. Continue to trend the response and the underlying disease; improvement does not by itself cancel ECMO-center planning. Measure methemoglobin within 4-8 hours and periodically thereafter.

---

NPS Exam Traps

[!WARNING]

Exam Trap 1: The "More is Better" Dosing Fallacy

If an infant does not respond to the recommended 20 ppm neonatal dose, routine escalation to 40 or 80 ppm is not recommended: higher doses increase $NO_2$ and methemoglobin exposure without demonstrated additional benefit. Verify delivery, lung recruitment, anatomy, ventricular function, and diagnosis, and activate the appropriate rescue pathway.

Exam Trap 2: Methylene Blue in G6PD Deficiency

Methylene blue requires caution or avoidance in known G6PD deficiency because response may be poor and hemolysis can occur. Reduce or stop the oxidant exposure first, support oxygen delivery, and obtain neonatal/toxicology direction for vitamin C, methylene blue, or transfusion rather than selecting treatment from ancestry.

Exam Trap 3: Rebound PPHN from Rapid Weaning

If severe hypoxemia and hypotension begin immediately after abrupt iNO discontinuation, reinstate the prior effective dose, support oxygenation and ventilation to prescribed targets, verify delivery, and treat hemodynamic instability while the team reassesses. A fixed $FiO_2$ of 1.00 is not mandatory when a lower concentration promptly meets the target.